Metastatic cutaneous melanoma: Updates from the 2024 European Society for Medical Oncology (ESMO) Annual Meeting

Metastatic cutaneous melanoma: Updates from the 2024 European Society for Medical Oncology (ESMO) Annual Meeting

In this online, self-learning activity: Melanoma is a tumor of the melanocytes primarily occurring in the skin. The fifth most common cancer in the U.S., it occurs in over 100,000 people annually and is attributable to over 8,200 deaths each year. It is also one of the most common cancers in young adults. The five-year survival rate from diagnosis overall is 80% to 99% for patients with early stages of the disease, depending on tumor thickness. However, in patients in whom the disease that has spread to adjacent lymph nodes or tissues, the five-year survival drops to 71%, and for those with distant metastases (five percent of cases are diagnosed at this stage), the five-year survival is 32%, representing an area of ongoing clinical need.

  • Provider:ScientiaCME
  • Activity Link: https://www.scientiacme.org
  • Start Date: 2025-01-31 06:00:00
  • End Date: 2025-01-31 06:00:00
  • Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
  • MOC Credit Details: ABIM - 1.0 Point; Credit Type(s): Medical Knowledge (ABIM)
  • Commercial Support: Source: Merck - Amount: 24768.0 - Is Kind Support: False
  • Activity Type: Enduring Material
  • CME Finder Type: Online Learning
  • Fee to Participate: No, it's free
  • Measured Outcome: Learner Competence, Learner Knowledge, Learner Performance
  • Provider Ship: Directly Provided
  • Registration: Open to all
  • Specialty: Medical Oncology
«
»
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x

Contact us

If you want to join leaders who will shape what Americans think about sleep.

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.

Sign up for the expert list

for media inquiries

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.